Therapeutic interventions, in particular for neovascular age-related macular degeneration (AMD) offer a better degree of value than any other treatment right across the field of healthcare.
Don’t miss our editorial advisory board members at the Floretina/ICOOR meeting
EAB members from Ophthalmology Times Europe, Ophthalmology Times and Modern Retina are presenting in Florence
Higher Molar Dose and Its Translation into Clinical Practice
The Floretina ICOOR meeting begins in Florence, Italy
What to expect from 4 days in the Fortezza de Basso
Adapting our understanding of cerebral visual impairment
The differential recruitment of the dorsal and ventral visual streams
Ethnic background has an impact on glaucoma outcomes
Gauging patient perceptions in an ethnically diverse UK cohort
Recyclable ophthalmic instrument company HASA OPTIX receives B Corporation certification
The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries